Cargando…

Is hydroxychloroquine beneficial for COVID-19 patients?

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019. As similar cases rapidly emerged around the world(1–3), the World Health Organization (WHO) declared a public health emergency of internatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xing, Wang, Ying, Agostinis, Patrizia, Rabson, Arnold, Melino, Gerry, Carafoli, Ernesto, Shi, Yufang, Sun, Erwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341710/ https://www.ncbi.nlm.nih.gov/pubmed/32641681 http://dx.doi.org/10.1038/s41419-020-2721-8

Ejemplares similares

Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
por: Carafoli, Ernesto
Publicado: (2021)

BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?
por: Sharma, Abhibhav, et al.
Publicado: (2020)

Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?
por: Verkhratsky, Alexei, et al.
Publicado: (2020)

The “Sharp” blade against HIF-mediated metastasis
por: Amelio, Ivano, et al.
Publicado: (2012)

Context is everything: extrinsic signalling and gain-of-function p53 mutants
por: Amelio, Ivano, et al.
Publicado: (2020)

The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19
por: Lee, Zelyn, et al.
Publicado: (2021)

Reflections on Participation in a Trial on Hydroxychloroquine as Prevention for COVID-19 among Health Workers in Niger
por: Kabore, Youssouf, et al.
Publicado: (2023)

Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
por: Ibáñez, Sebastián, et al.
Publicado: (2020)

Lopinavir/ritonavir use in Covid-19 infection: is it completely non-beneficial?
por: Owa, Adewale Bayode, et al.
Publicado: (2020)

Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice?
por: Pothen, Lucie, et al.
Publicado: (2021)

Hydroxychloroquine for Treatment of SARS‐CoV‐2 Infection? Improving Our Confidence in a Model‐Based Approach to Dose Selection
por: Arnold, Samuel L.M., et al.
Publicado: (2020)

Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs
por: Yu, Bo, et al.
Publicado: (2020)

COVID-19 infection: the China and Italy perspectives
por: Chen, Jun, et al.
Publicado: (2020)

Remdesivir: From Ebola to COVID-19
por: Santoro, M. Gabriella, et al.
Publicado: (2021)

Actively or passively deacidified lysosomes push β-coronavirus egress
por: Wang, Xuefeng, et al.
Publicado: (2021)

Are statins beneficial for the treatment of pulmonary hypertension?
por: Wang, Lei, et al.
Publicado: (2017)

COVID19: an announced pandemic
por: Platto, Sara, et al.
Publicado: (2020)

Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings
por: Abena, Pascale M., et al.
Publicado: (2020)

Introduction: the Critical Connection Between COVID-19 and Employment
por: Nathan, Dev, et al.
Publicado: (2020)

Survey of Members of the Indian Society of Labour Economics on the COVID-19 Crisis and Employment
por: Rodgers, Gerry
Publicado: (2020)

COVID-19 infection: the perspectives on immune responses
por: Shi, Yufang, et al.
Publicado: (2020)

Why Companion Animals Are Beneficial During COVID-19 Pandemic
por: Hunjan, Unnati G, et al.
Publicado: (2020)

Recent advances in cancer immunotherapy
por: Sun, Qiang, et al.
Publicado: (2021)

Beneficial effects of date palm fruits on neurodegenerative diseases
por: Essa, Musthafa Mohamed, et al.
Publicado: (2016)

Assessing spirituality: is there a beneficial role in the management of COPD?
por: Gergianaki, Irini, et al.
Publicado: (2019)

A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19)
por: Keshtkar-Jahromi, Maryam, et al.
Publicado: (2020)

Hydroxychloroquine plus azithromycin and early hospital admission are beneficial in COVID-19 patients: Turkish experience with real-life data
por: TANRIVERDİ, Elif, et al.
Publicado: (2021)

Bioinformatics analysis of the serine and glycine pathway in cancer cells
por: Antonov, Alexey, et al.
Publicado: (2014)

New Consensus pattern in Spike CoV-2: potential implications in coagulation process and cell–cell fusion
por: Buonvino, Silvia, et al.
Publicado: (2020)

Bridging the Gap: Type III Secretion Systems in Plant-Beneficial Bacteria
por: Zboralski, Antoine, et al.
Publicado: (2022)

Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
por: Verbaanderd, Ciska, et al.
Publicado: (2017)

Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers
por: Rotblat, Barak, et al.
Publicado: (2013)

History of the COVID-19 pandemic: Origin, explosion, worldwide spreading
por: Platto, Sara, et al.
Publicado: (2021)

Beneficial effects of AAV1-Rheb(S16H) administration in the adult hippocampus
por: Kim, Sang Ryong
Publicado: (2020)

Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia
por: Mauriello, Alessandro, et al.
Publicado: (2021)

p53-Mediated Tumor Suppression: DNA-Damage Response and Alternative Mechanisms
por: Pitolli, Consuelo, et al.
Publicado: (2019)

Do Mutations Turn p53 into an Oncogene?
por: Pitolli, Consuelo, et al.
Publicado: (2019)

Orchestration of Mesenchymal Stem/Stromal Cells and Inflammation During Wound Healing
por: Zhu, Mengting, et al.
Publicado: (2023)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Hydroxychloroquine and COVID-19: The endgame!
por: Deplanque, Dominique
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tuq0rrlf0a266umsvnf8e7vrm6